In summary, our study demonstrates that Curcumol inhibits colorectal cancer (CRC) progression by activating the VHL/HIF-1α pathway, suppressing glycolysis and lactate production, and improving tumor microenvironment. Here, VHL is linked to colorectal carcinoma.